跳至主要内容
临床试验/PACTR202003522049711
PACTR202003522049711暂停2 期

The effect of aspirin on human immunodeficiency virus (hiv) disease progression among hiv- infected individuals initiating antiretroviral therapy.

MUHAS0 个研究点目标入组 454 人开始时间: 2020年2月10日最近更新:

试验速览

阶段
2 期
状态
暂停
发起方
MUHAS
入组人数
454

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Consenting newly recruited male or female HIV-infected patients
  • ARV drugs naïve initiating on ARV drugs
  • Aged 18 years and above
  • Willing to stay in Dar es salaam for at least six consecutive months
  • Willing to attend HIV clinics at Temeke or Mbagala Rangi Tatu or Mwananyamala hospitals for at least six consecutive months

排除标准

  • Previous intolerance or allergy to ASA or any ASA products
  • Current or History of recurrent Peptic Ulcer Disease (PUD)
  • Predisposition to bleeding
  • Antithrombotic therapy
  • Therapy with prohibited drugs (see appendix 5)
  • Active or history of peptic ulcer disease
  • Severe renal disease (eGFR <30 mil/min/1.73 m2)

研究者

发起方
MUHAS

相似试验